Theriva Biologics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Theriva Biologics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q3 2024.
  • Theriva Biologics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $1.43M, a 22% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.43M -$403K -22% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $1.52M -$437K -22.3% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $1.63M -$420K -20.4% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $1.76M +$560K +46.7% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $1.83M +$585K +47% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $1.96M +$664K +51.4% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $2.05M +$716K +53.5% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $1.2M -$184K -13.3% Dec 31, 2022 10-K 2024-03-25
Q3 2022 $1.25M -$180K -12.6% Sep 30, 2022 10-K 2023-03-30
Q2 2022 $1.29M -$176K -12% Jun 30, 2022 10-K 2023-03-30
Q1 2022 $1.34M +$1.1M +460% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $1.38M +$1.1M +396% Dec 31, 2021 10-K 2023-03-30
Q3 2021 $1.43M +$1.11M +351% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $1.47M +$1.12M +317% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $239K -$147K -38.1% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $279K -$140K -33.4% Dec 31, 2020 10-K 2022-03-16
Q3 2020 $316K -$135K -29.9% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 $352K -$129K -26.8% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $386K -$124K -24.3% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 $419K +$419K Dec 31, 2019 10-K 2021-03-04
Q3 2019 $451K Sep 30, 2019 10-Q 2019-11-04
Q2 2019 $481K Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $510K Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $0 Dec 31, 2018 10-K 2020-02-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.